Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate
about
A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplicationWhere Failure Is Not an Option -Personalized Medicine in AstronautsAssociation of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patients.Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulationsSLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to β-Blockers in Hypertensive African AmericansCardiovascular Pharmacogenomics--Implications for Patients With CKD.Multiplex SNaPshot-a new simple and efficient CYP2D6 and ADRB1 genotyping method.Factors affecting the development of adverse drug reactions to β-blockers in hospitalized cardiac patient populationAn update on the pharmacogenetics of treating hypertension.Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.An accurate and precise representation of drug ingredients.CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure.Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers.Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics.Hypertension Across a Woman's Life Cycle.Genome Wide Association Study Identifies the HMGCS2 Locus to be Associated With Chlorthalidone Induced Glucose Increase in Hypertensive Patients.Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers.Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies.
P2860
Q28543107-FA6C75AF-6455-4DA1-8573-C54354CAF36DQ28550427-EF6808DD-D547-47BD-8325-E5E4BDEE131DQ35900537-73C4F9B8-9C34-4983-B0C4-1C43F223CAFDQ36243622-75A39180-80C6-40C0-9DAA-256E33F0C170Q36321069-61340822-DE0F-4289-B977-394911937005Q36576519-BCE1CEE7-4CF4-42CE-AA2A-05339567C499Q36696635-61B75215-C8D6-4AAE-BFE7-CF12741249BCQ36828958-AD19228A-7AD4-42B1-9BF7-FE94E98CBB7DQ37158873-75A41F70-E509-40F0-B0C8-DBA0229736A3Q38263731-8E10DECC-A55B-46A6-949A-F2EF6672BD94Q38381894-432DE9EC-E7ED-4381-87A0-F5F0333F6AD7Q38393436-4E7F53C5-841A-4450-9BFF-38FC3450E504Q39127810-EDD8B8EB-340A-4D81-AD3B-9BB0876C0E52Q39239760-B2DFCC5C-7296-489B-B190-21E3195EADA4Q42731799-895F7E19-F606-4B14-8A52-4DE3F41CE0C8Q47193469-C29DE432-5772-408B-82C2-5F846A27023AQ52577307-0EE2DC90-4E79-4B4D-B2C4-1969B99A888BQ52663751-8D8A4460-A432-4724-86B3-D503F6545F34Q52686636-CA54B5B3-B72A-4050-B6E0-DE50201E6A20Q55315738-FA92DEE4-6707-4BC1-B8DF-63483AA429DF
P2860
Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Impact of CYP2D6 polymorphisms ...... ability of metoprolol tartrate
@ast
Impact of CYP2D6 polymorphisms ...... ability of metoprolol tartrate
@en
type
label
Impact of CYP2D6 polymorphisms ...... ability of metoprolol tartrate
@ast
Impact of CYP2D6 polymorphisms ...... ability of metoprolol tartrate
@en
prefLabel
Impact of CYP2D6 polymorphisms ...... ability of metoprolol tartrate
@ast
Impact of CYP2D6 polymorphisms ...... ability of metoprolol tartrate
@en
P2093
P2860
P356
P1476
Impact of CYP2D6 polymorphisms ...... ability of metoprolol tartrate
@en
P2093
A B Chapman
B M Burkley
I S Hamadeh
J A Johnson
R M Cooper-DeHoff
S T Turner
P2860
P304
P356
10.1038/CLPT.2014.62
P407
P577
2014-03-17T00:00:00Z